EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

Eddy Sokolaj iD, Neda Assareh iD, Kristen Anderson iD, Karin R Aubrey iD, Christopher W Vaughan iD

Journal of Neurochemistry · 2024

DOI: 10.1111/jnc.15964 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, 2024. Verfasst von Eddy Sokolaj und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pain Management Research Institute, Kolling Institute of Medical Research, Northern Clinical School, Royal North Shore Hospital, University of Sydney…. Hauptthemen laut MEDLINE: Neuralgia, Cannabis, Chronic Pain. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 166 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic neuropathic pain is a debilitating pain syndrome caused by damage to the nervous system that is poorly served by current medications. Given these problems, clinical studies have pursued extracts of the plant Cannabis sativa as alternative treatments for this condition. The vast majority of these studies have examined cannabinoids which contain the psychoactive constituent delta‐9‐tetrahydrocannabinol (THC). While there have been some positive findings, meta‐analyses of this clinical work indicates that this effectiveness is limited and hampered by side‐effects. This review focuses on how recent preclinical studies have predicted the clinical limitations of THC‐containing cannabis extracts, and importantly, point to how they might be improved. This work highlights the importance of targeting channels and receptors other than cannabinoid CB1 receptors which mediate many of the side‐effects of cannabis. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaCannabisChronic PainAnimalsHumansDronabinolCannabinoidsPlant ExtractsMedical Marijuana

Stichwörter der Autor:innen

cannabidiolcannabisdelta‐9‐tetrahydrocannibinolion channelneuropathic painreceptor

Substanzen

DronabinolCannabinoidsPlant ExtractsMedical Marijuana

Autor:innen und Institutionen

  • Pain Management Research Institute, Kolling Institute of Medical Research, Northern Clinical School, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Eddy Sokolaj, Neda Assareh, Kristen Anderson, Karin R Aubrey, Christopher W Vaughan

Zitieren

APA

Sokolaj, E., Assareh, N., Anderson, K., Aubrey, K. R., & Vaughan, C. W. (2024). Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15964

Vancouver

Sokolaj E, Assareh N, Anderson K, Aubrey KR, Vaughan CW. Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence. Journal of Neurochemistry. 2024. doi:10.1111/jnc.15964

BibTeX
@article{Sokolaj2024,
  author = {Sokolaj, Eddy and Assareh, Neda and Anderson, Kristen and Aubrey, Karin R and Vaughan, Christopher W},
  title = {Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence},
  journal = {Journal of Neurochemistry},
  year = {2024},
  doi = {10.1111/jnc.15964}
}
Kostenlos starten →